Format

Send to

Choose Destination
See comment in PubMed Commons below
Toxicol Pathol. 2010 Jan;38(1):62-71. doi: 10.1177/0192623309354109. Epub 2009 Nov 17.

Mouse models for cancer stem cell research.

Author information

1
Department of Biomedical Sciences, Cornell University, Ithaca, NY 14853, USA.

Abstract

The cancer stem cell concept assumes that cancers are mainly sustained by a small pool of neoplastic cells, known as cancer stem cells or tumor initiating cells, which are able to reproduce themselves and produce phenotypically heterogeneous cells with lesser tumorigenic potential. Cancer stem cells represent an appealing target for development of more selective and efficient therapies. However, direct testing of the cancer stem cell concept and assessment of its therapeutic implications in human cancers have been complicated by the use of immunocompromised mice. Genetically defined immunocompetent autochthonous mouse models of human cancer provide a valuable tool to address this problem. Furthermore, they allow for a better understanding of the relevance of mechanisms controlling normal stem cell compartment to carcinogenesis. Advantages and disadvantages of some of the existing mouse models are reviewed, and future challenges in cancer stem cell research are outlined.

PMID:
19920280
PMCID:
PMC2827660
DOI:
10.1177/0192623309354109
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Support Center